SCHEMBL175469

SCHEMBL175469

C=CC(N)N1CCOCC1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.31
DPP4 P27487 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5140693 0.82
SCHEMBL8078329 0.82
Hydrochloric Acid SCHEMBL20899797 0.79 MAPT (0.38) ANPEP
SCHEMBL1169811 0.77
SCHEMBL5878510 0.76 ALDH1A1 (0.32) ANPEPDPP4
SCHEMBL1934289 0.75 DPP7 (0.33)
SCHEMBL11761722 0.73 ALDH1A1 (0.30)
SCHEMBL4805804 0.72
SCHEMBL10662577 0.71 ALDH1A1 (0.31) DPP4
SCHEMBL175415 0.71 MEN1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 894 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12031111-B2 Xylose carbamates as soil release agents HENKEL AG & CO. KGAA (DE) 2024-07-09 US claimed
US-20240074437-A1 SURFACE ANTIMICROBIAL TREATMENTS Crossing S.r.l. (IT) 2024-03-07 US claimed
EP-4258879-A1 SURFACE ANTIMICROBIAL TREATMENTS Crossing S.r.l. (IT) 2023-10-18 EP claimed
EP-3810742-B1 XYLOSE CARBAMATES AS SOIL RELEASE AGENTS HENKEL AG & CO KGAA (DE) 2022-08-03 EP claimed
WO-2022123441-A1 SURFACE ANTIMICROBIAL TREATMENTS Crossing S.r.l. (IT) 2022-06-16 WO claimed
EP-3810742-A1 XYLOSE CARBAMATES AS SOIL RELEASE AGENTS Henkel AG & Co. KGaA (DE) 2021-04-28 EP claimed
US-20210115358-A1 Xylose Carbamates As Soil Release Agents HENKEL AG & CO. KGAA (DE) 2021-04-22 US claimed
EP-3555246-B1 MULTI-FUNCTIONAL OLEFIN COPOLYMERS AND LUBRICATING COMPOSITIONS CONTAINING SAME AFTON CHEMICAL CORP (US) 2020-11-25 EP claimed
WO-2019243071-A1 XYLOSE CARBAMATES AS SOIL RELEASE AGENTS HENKEL AG & CO. KGAA (DE) 2019-12-26 WO claimed
EP-3555246-A1 MULTI-FUNCTIONAL OLEFIN COPOLYMERS AND LUBRICATING COMPOSITIONS CONTAINING SAME Afton Chemical Corporation (US) 2019-10-23 EP claimed
CN-1322712-A Succinimide-acid compound and its derivative ETHYL CORP (US) 2001-11-21 CN claimed
EP-1151994-A1 Succinimide-acid compounds and derivatives thereof ETHYL CORPORATION (US) 2001-11-07 EP claimed
US-6248801-B1 CELL OPENING ADJUVANTS AIR PRODUCTS AND CHEMICALS, INC. 2001-06-19 US claimed
EP-1099718-A2 Tertiary amine-containing active methylene compounds for improving the dimensional stability of polyurethane foam AIR PRODUCTS AND CHEMICALS, INC. (US) 2001-05-16 EP claimed
US-6111056-A Cyclic amine based polymers and process for their production BASF AKTIENGESELLSCHAFT (DE) 2000-08-29 US claimed
US-4866135-A ADDUCT WITH ALPHA-OLEFIN COPOLYMER GRAFTED WITH UNSATURATED CARBOXYLIC UNITS EXXON CHEMICAL PATENTS INC. (US) 1989-09-12 US claimed
US-4357250-A DIENE-ETHYLENE-PROPYLENE TERPOLYMER, UNSATURATED ACID, AMINE THE LUBRIZOL CORPORATION (US) 1982-11-02 US claimed
EP-0050025-A2 Molybdenum-containing aminated sulfurized olefin lubricating oil additives Standard Oil Company (US) 1982-04-21 EP claimed
US-4320019-A Multi-purpose additive compositions and concentrates containing same THE LUBRIZOL CORPORATION (US) 1982-03-16 US claimed
US-4292185-A COMPRISING A DIENE-MODIFIED MONOOLEFINIC POLYMER REACTED WITH CHLOROSULFONYL ISOCYANATE AND THEN WITH AN AMINE ROHM AND HAAS COMPANY (US) 1981-09-29 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240074437-A1 SURFACE ANTIMICROBIAL TREATMENTS CUTA, ETF1, SFN ANPEP 1096/4885DPP4 2729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.